Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses.
Hao S, Ling XB, Kanegaye JT, Bainto E, Dominguez SR, Heizer H, Jone PN, Anderson MS, Jaggi P, Baker A, Son MB, Newburger JW, Ashouri N, McElhinney DB, Burns JC, Whitin JC, Cohen HJ, Tremoulet AH; Pediatric Emergency Medicine Kawasaki Disease Research Group. Hao S, et al. Among authors: jone pn. Arch Dis Child. 2020 Aug;105(8):772-777. doi: 10.1136/archdischild-2019-317980. Epub 2020 Mar 5. Arch Dis Child. 2020. PMID: 32139365
Concurrent Respiratory Viruses and Kawasaki Disease.
Turnier JL, Anderson MS, Heizer HR, Jone PN, Glodé MP, Dominguez SR. Turnier JL, et al. Among authors: jone pn. Pediatrics. 2015 Sep;136(3):e609-14. doi: 10.1542/peds.2015-0950. Epub 2015 Aug 24. Pediatrics. 2015. PMID: 26304824
Myocardial Perfusion Reserve Index in Children With Kawasaki Disease.
Friesen RM, Schäfer M, Jone PN, Appiawiah N, Vargas D, Fonseca B, DiMaria MV, Truong U, Malone L, Browne LP. Friesen RM, et al. Among authors: jone pn. J Magn Reson Imaging. 2018 Jul;48(1):132-139. doi: 10.1002/jmri.25922. Epub 2017 Dec 12. J Magn Reson Imaging. 2018. PMID: 29232024
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.
Roberts SC, Jain S, Tremoulet AH, Kim KK, Burns JC; KIDCARE Multicenter Study Group; Anand V, Anderson M, Ang J, Ansusinha E, Arditi M, Ashouri N, Bartlett A, Chatterjee A, DeBiasi R, Dekker C, DeZure C, Didion L, Dominguez S, El Feghaly R, Erdem G, Halasa N, Harahsheh A, Jackson MA, Jaggi P, Jain S, Jone PN, Kaushik N, Kurio G, Lillian A, Lloyd D, Manaloor J, McNelis A, Michalik DE, Newburger J, Newcomer C, Perkins T, Portman M, Romero J, Ronis T, Rowley A, Schneider K, Schuster J, Tejtel SKS, Sharma K, Simonsen K, Szmuszkovicz J, Truong D, Wood J, Yeh S. Roberts SC, et al. Among authors: jone pn. Contemp Clin Trials. 2019 Apr;79:98-103. doi: 10.1016/j.cct.2019.02.008. Epub 2019 Mar 3. Contemp Clin Trials. 2019. PMID: 30840903 Free article.
97 results